

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.44661450 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 5.44661450 |
| 3 | complement activation, alternative pathway (GO:0006957) | 5.37369937 |
| 4 | regulation of protein activation cascade (GO:2000257) | 5.25787514 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 5.15282851 |
| 6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.14257141 |
| 7 | L-phenylalanine metabolic process (GO:0006558) | 5.14257141 |
| 8 | indole-containing compound catabolic process (GO:0042436) | 4.96475775 |
| 9 | indolalkylamine catabolic process (GO:0046218) | 4.96475775 |
| 10 | tryptophan catabolic process (GO:0006569) | 4.96475775 |
| 11 | regulation of complement activation (GO:0030449) | 4.95066015 |
| 12 | protein carboxylation (GO:0018214) | 4.90916837 |
| 13 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.90916837 |
| 14 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.88609445 |
| 15 | kynurenine metabolic process (GO:0070189) | 4.79193796 |
| 16 | urea cycle (GO:0000050) | 4.70502777 |
| 17 | urea metabolic process (GO:0019627) | 4.70502777 |
| 18 | tryptophan metabolic process (GO:0006568) | 4.64646498 |
| 19 | negative regulation of fibrinolysis (GO:0051918) | 4.52645802 |
| 20 | bile acid biosynthetic process (GO:0006699) | 4.51827676 |
| 21 | regulation of fibrinolysis (GO:0051917) | 4.36681909 |
| 22 | cysteine metabolic process (GO:0006534) | 4.31702364 |
| 23 | high-density lipoprotein particle remodeling (GO:0034375) | 4.27409832 |
| 24 | nitrogen cycle metabolic process (GO:0071941) | 4.26779415 |
| 25 | sulfur amino acid catabolic process (GO:0000098) | 4.06819349 |
| 26 | reverse cholesterol transport (GO:0043691) | 4.04958005 |
| 27 | glyoxylate metabolic process (GO:0046487) | 4.04244210 |
| 28 | alpha-linolenic acid metabolic process (GO:0036109) | 4.03957060 |
| 29 | negative regulation of protein activation cascade (GO:2000258) | 4.00222275 |
| 30 | homocysteine metabolic process (GO:0050667) | 3.99498556 |
| 31 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.99489392 |
| 32 | epoxygenase P450 pathway (GO:0019373) | 3.88160214 |
| 33 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.84072710 |
| 34 | bile acid metabolic process (GO:0008206) | 3.81467783 |
| 35 | fibrinolysis (GO:0042730) | 3.80553286 |
| 36 | coenzyme catabolic process (GO:0009109) | 3.79820768 |
| 37 | protein-lipid complex remodeling (GO:0034368) | 3.74537806 |
| 38 | macromolecular complex remodeling (GO:0034367) | 3.74537806 |
| 39 | plasma lipoprotein particle remodeling (GO:0034369) | 3.74537806 |
| 40 | regulation of triglyceride catabolic process (GO:0010896) | 3.70015706 |
| 41 | exogenous drug catabolic process (GO:0042738) | 3.69305260 |
| 42 | aromatic amino acid family metabolic process (GO:0009072) | 3.67306773 |
| 43 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.65669503 |
| 44 | acute-phase response (GO:0006953) | 3.63176041 |
| 45 | phospholipid efflux (GO:0033700) | 3.62845885 |
| 46 | plasma lipoprotein particle clearance (GO:0034381) | 3.61714472 |
| 47 | cholesterol efflux (GO:0033344) | 3.60440788 |
| 48 | complement activation, classical pathway (GO:0006958) | 3.59673213 |
| 49 | regulation of cholesterol esterification (GO:0010872) | 3.56957922 |
| 50 | xenobiotic catabolic process (GO:0042178) | 3.56882746 |
| 51 | bile acid and bile salt transport (GO:0015721) | 3.55638036 |
| 52 | indolalkylamine metabolic process (GO:0006586) | 3.55053024 |
| 53 | tyrosine metabolic process (GO:0006570) | 3.53608690 |
| 54 | complement activation (GO:0006956) | 3.52248330 |
| 55 | acylglycerol homeostasis (GO:0055090) | 3.50766297 |
| 56 | triglyceride homeostasis (GO:0070328) | 3.50766297 |
| 57 | omega-hydroxylase P450 pathway (GO:0097267) | 3.48309960 |
| 58 | lysine metabolic process (GO:0006553) | 3.47739257 |
| 59 | lysine catabolic process (GO:0006554) | 3.47739257 |
| 60 | serine family amino acid catabolic process (GO:0009071) | 3.46534648 |
| 61 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.45537868 |
| 62 | cellular glucuronidation (GO:0052695) | 3.44251980 |
| 63 | opsonization (GO:0008228) | 3.39983026 |
| 64 | cellular ketone body metabolic process (GO:0046950) | 3.38212289 |
| 65 | phospholipid homeostasis (GO:0055091) | 3.35225588 |
| 66 | cellular modified amino acid catabolic process (GO:0042219) | 3.35061086 |
| 67 | protein activation cascade (GO:0072376) | 3.34330409 |
| 68 | cytolysis (GO:0019835) | 3.31712667 |
| 69 | heme transport (GO:0015886) | 3.30010013 |
| 70 | cellular biogenic amine catabolic process (GO:0042402) | 3.28954571 |
| 71 | amine catabolic process (GO:0009310) | 3.28954571 |
| 72 | glutamate metabolic process (GO:0006536) | 3.25434659 |
| 73 | negative regulation of cholesterol transport (GO:0032375) | 3.24846951 |
| 74 | negative regulation of sterol transport (GO:0032372) | 3.24846951 |
| 75 | cofactor catabolic process (GO:0051187) | 3.23669917 |
| 76 | vitamin biosynthetic process (GO:0009110) | 3.23370067 |
| 77 | alpha-amino acid catabolic process (GO:1901606) | 3.22497807 |
| 78 | uronic acid metabolic process (GO:0006063) | 3.20394752 |
| 79 | glucuronate metabolic process (GO:0019585) | 3.20394752 |
| 80 | regulation of cholesterol homeostasis (GO:2000188) | 3.16132741 |
| 81 | benzene-containing compound metabolic process (GO:0042537) | 3.14773553 |
| 82 | eosinophil chemotaxis (GO:0048245) | 3.14698687 |
| 83 | lipoprotein metabolic process (GO:0042157) | 3.14025417 |
| 84 | arginine metabolic process (GO:0006525) | 3.13812048 |
| 85 | amino-acid betaine metabolic process (GO:0006577) | 3.13154251 |
| 86 | regulation of plasminogen activation (GO:0010755) | 3.10074477 |
| 87 | positive regulation of heat generation (GO:0031652) | 3.07760092 |
| 88 | positive regulation of lipid catabolic process (GO:0050996) | 3.07537791 |
| 89 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.04536018 |
| 90 | aldehyde catabolic process (GO:0046185) | 3.02303838 |
| 91 | plasma lipoprotein particle assembly (GO:0034377) | 3.01230639 |
| 92 | cellular amino acid catabolic process (GO:0009063) | 2.98947262 |
| 93 | regulation of humoral immune response (GO:0002920) | 2.98819736 |
| 94 | phenylpropanoid metabolic process (GO:0009698) | 2.98361869 |
| 95 | transcytosis (GO:0045056) | 2.93931511 |
| 96 | drug catabolic process (GO:0042737) | 2.93625882 |
| 97 | positive regulation of calcium ion import (GO:0090280) | 2.93146510 |
| 98 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.92673508 |
| 99 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.92673508 |
| 100 | S-adenosylmethionine metabolic process (GO:0046500) | 2.91954767 |
| 101 | low-density lipoprotein particle remodeling (GO:0034374) | 2.89757307 |
| 102 | regulation of bile acid biosynthetic process (GO:0070857) | 2.88284885 |
| 103 | plasma lipoprotein particle organization (GO:0071827) | 2.87930753 |
| 104 | ketone body metabolic process (GO:1902224) | 2.86367293 |
| 105 | regulation of fever generation (GO:0031620) | 2.85142050 |
| 106 | negative regulation of hemostasis (GO:1900047) | 2.84700267 |
| 107 | negative regulation of blood coagulation (GO:0030195) | 2.84700267 |
| 108 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 2.84560940 |
| 109 | negative regulation of complement activation (GO:0045916) | 2.84272645 |
| 110 | oligosaccharide catabolic process (GO:0009313) | 2.83945197 |
| 111 | protein-lipid complex assembly (GO:0065005) | 2.83710780 |
| 112 | drug transmembrane transport (GO:0006855) | 2.83569202 |
| 113 | positive regulation of blood coagulation (GO:0030194) | 2.82399906 |
| 114 | positive regulation of hemostasis (GO:1900048) | 2.82399906 |
| 115 | regulation of heat generation (GO:0031650) | 2.81151569 |
| 116 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.81070630 |
| 117 | protein-lipid complex subunit organization (GO:0071825) | 2.78615989 |
| 118 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.78182563 |
| 119 | eosinophil migration (GO:0072677) | 2.74831331 |
| 120 | regulation of mononuclear cell migration (GO:0071675) | 2.73991358 |
| 121 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.73941619 |
| 122 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.63257462 |
| 123 | regulation of hexokinase activity (GO:1903299) | 2.63194180 |
| 124 | regulation of glucokinase activity (GO:0033131) | 2.63194180 |
| 125 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.56902559 |
| 126 | retinal metabolic process (GO:0042574) | 2.56635354 |
| 127 | drug metabolic process (GO:0017144) | 2.52027603 |
| 128 | positive regulation of glycolytic process (GO:0045821) | 2.51643751 |
| 129 | retinol metabolic process (GO:0042572) | 2.48801158 |
| 130 | iron coordination entity transport (GO:1901678) | 2.48270933 |
| 131 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.47669082 |
| 132 | endocrine pancreas development (GO:0031018) | 2.47301016 |
| 133 | oxidative demethylation (GO:0070989) | 2.45786791 |
| 134 | nitric oxide biosynthetic process (GO:0006809) | 2.45274719 |
| 135 | zinc ion transport (GO:0006829) | 2.44828633 |
| 136 | vitamin D metabolic process (GO:0042359) | 2.44479583 |
| 137 | regulation of chronic inflammatory response (GO:0002676) | 2.43875664 |
| 138 | positive regulation of prostaglandin secretion (GO:0032308) | 2.43801408 |
| 139 | membrane lipid catabolic process (GO:0046466) | 2.42989153 |
| 140 | regulation of acrosome reaction (GO:0060046) | 2.42825877 |
| 141 | flavonoid metabolic process (GO:0009812) | 2.42635283 |
| 142 | macroautophagy (GO:0016236) | 2.41781678 |
| 143 | positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:00357 | 2.40793141 |
| 144 | platelet dense granule organization (GO:0060155) | 2.40532027 |
| 145 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 2.40067672 |
| 146 | regulation of prostaglandin secretion (GO:0032306) | 2.37192219 |
| 147 | vasodilation (GO:0042311) | 2.35256652 |
| 148 | insulin secretion (GO:0030073) | 2.33082099 |
| 149 | sphingolipid catabolic process (GO:0030149) | 2.32006721 |
| 150 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.30450341 |
| 151 | regulation of vitamin metabolic process (GO:0030656) | 2.29477125 |
| 152 | negative regulation of coagulation (GO:0050819) | 2.29399595 |
| 153 | urate metabolic process (GO:0046415) | 2.29352851 |
| 154 | positive regulation of nitric oxide biosynthetic process (GO:0045429) | 2.28111303 |
| 155 | peptide hormone processing (GO:0016486) | 2.27682386 |
| 156 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 2.27562138 |
| 157 | magnesium ion transport (GO:0015693) | 2.26903736 |
| 158 | sphingosine metabolic process (GO:0006670) | 2.26860890 |
| 159 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 2.26464996 |
| 160 | cobalamin metabolic process (GO:0009235) | 2.24781214 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 7.10035470 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.08011009 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.23764485 |
| 4 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 4.20997171 |
| 5 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.20755177 |
| 6 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.03409784 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.23941209 |
| 8 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.01128021 |
| 9 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.58174447 |
| 10 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.20048064 |
| 11 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.97809782 |
| 12 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.94251681 |
| 13 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.93298874 |
| 14 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.90863022 |
| 15 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.58874018 |
| 16 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.57333425 |
| 17 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.54148030 |
| 18 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.52717322 |
| 19 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.52710009 |
| 20 | VDR_22108803_ChIP-Seq_LS180_Human | 1.52450018 |
| 21 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.52184429 |
| 22 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.52184429 |
| 23 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.49210977 |
| 24 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.48976635 |
| 25 | * EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.46132109 |
| 26 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.45971375 |
| 27 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.45450134 |
| 28 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.45366292 |
| 29 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.42346597 |
| 30 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.42248948 |
| 31 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.41577830 |
| 32 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.41239985 |
| 33 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.40308371 |
| 34 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.38870690 |
| 35 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.38870690 |
| 36 | * EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.37923786 |
| 37 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.36970997 |
| 38 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.36123030 |
| 39 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.36092182 |
| 40 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.35369365 |
| 41 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.34684975 |
| 42 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.34398706 |
| 43 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.32559770 |
| 44 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.31307695 |
| 45 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.31036879 |
| 46 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.30777565 |
| 47 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.30637192 |
| 48 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.30458183 |
| 49 | FUS_26573619_Chip-Seq_HEK293_Human | 1.28402339 |
| 50 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.28002513 |
| 51 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.26938851 |
| 52 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.26646967 |
| 53 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.25924845 |
| 54 | * SOX2_19829295_ChIP-Seq_ESCs_Human | 1.25690775 |
| 55 | * NANOG_19829295_ChIP-Seq_ESCs_Human | 1.25690775 |
| 56 | * CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.24947055 |
| 57 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.24505262 |
| 58 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.23989432 |
| 59 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.23591121 |
| 60 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.23544603 |
| 61 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.23139621 |
| 62 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.22505319 |
| 63 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.21536293 |
| 64 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.21052892 |
| 65 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.20621513 |
| 66 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.20509213 |
| 67 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.20278509 |
| 68 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.19582604 |
| 69 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.19484211 |
| 70 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.19083628 |
| 71 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.16954413 |
| 72 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.16248886 |
| 73 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.14287598 |
| 74 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.14085905 |
| 75 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.13794048 |
| 76 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.13182876 |
| 77 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.12953840 |
| 78 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.12034726 |
| 79 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 1.11451430 |
| 80 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.11098761 |
| 81 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.10958589 |
| 82 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.09683837 |
| 83 | PU1_27457419_Chip-Seq_LIVER_Mouse | 1.08436638 |
| 84 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.07866175 |
| 85 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.07028795 |
| 86 | * OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.05632135 |
| 87 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.05065895 |
| 88 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.04695366 |
| 89 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.04580062 |
| 90 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.03413106 |
| 91 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.03384932 |
| 92 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.02207637 |
| 93 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.01305294 |
| 94 | CJUN_26792858_Chip-Seq_BT549_Human | 1.00971741 |
| 95 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.00694905 |
| 96 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.98890896 |
| 97 | GATA1_22025678_ChIP-Seq_K562_Human | 0.97554609 |
| 98 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.97479279 |
| 99 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.95254625 |
| 100 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.95041646 |
| 101 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.94016073 |
| 102 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.93755810 |
| 103 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.93348385 |
| 104 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.93279624 |
| 105 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.91892530 |
| 106 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.91165813 |
| 107 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.90906909 |
| 108 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.90176132 |
| 109 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.89960409 |
| 110 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.88565586 |
| 111 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.88564270 |
| 112 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.88188818 |
| 113 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.86577585 |
| 114 | AR_25329375_ChIP-Seq_VCAP_Human | 0.83540292 |
| 115 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.83506391 |
| 116 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.83337624 |
| 117 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.82687531 |
| 118 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.82185497 |
| 119 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.81958797 |
| 120 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.81311037 |
| 121 | P300_19829295_ChIP-Seq_ESCs_Human | 0.81302155 |
| 122 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.80795126 |
| 123 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.80555010 |
| 124 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.80063804 |
| 125 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.80056610 |
| 126 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.78682486 |
| 127 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.76667655 |
| 128 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.76086098 |
| 129 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.75605599 |
| 130 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.74992344 |
| 131 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.74990296 |
| 132 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.74589985 |
| 133 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.73845720 |
| 134 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.73813055 |
| 135 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.73490387 |
| 136 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.72180057 |
| 137 | RXR_22108803_ChIP-Seq_LS180_Human | 0.71665523 |
| 138 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.71115345 |
| 139 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.70510265 |
| 140 | TP53_16413492_ChIP-PET_HCT116_Human | 0.69946560 |
| 141 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.69645112 |
| 142 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.69387279 |
| 143 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.69370247 |
| 144 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.68870367 |
| 145 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.68679271 |
| 146 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.68298116 |
| 147 | KDM2B_26808549_Chip-Seq_REH_Human | 0.67534521 |
| 148 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.67328927 |
| 149 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.66806220 |
| 150 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.66663117 |
| 151 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.66435258 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 6.84251511 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 6.82009819 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.08049605 |
| 4 | MP0005365_abnormal_bile_salt | 4.76631831 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 3.79085880 |
| 6 | MP0003252_abnormal_bile_duct | 3.51073228 |
| 7 | MP0010329_abnormal_lipoprotein_level | 3.00743603 |
| 8 | MP0003195_calcinosis | 2.99108363 |
| 9 | MP0009840_abnormal_foam_cell | 2.72993134 |
| 10 | MP0003806_abnormal_nucleotide_metabolis | 2.53876611 |
| 11 | MP0003191_abnormal_cellular_cholesterol | 2.52046316 |
| 12 | MP0005332_abnormal_amino_acid | 2.42317191 |
| 13 | MP0002837_dystrophic_cardiac_calcinosis | 2.38990066 |
| 14 | MP0001666_abnormal_nutrient_absorption | 2.30667924 |
| 15 | MP0005083_abnormal_biliary_tract | 2.27609439 |
| 16 | MP0005379_endocrine/exocrine_gland_phen | 2.19051236 |
| 17 | MP0002138_abnormal_hepatobiliary_system | 2.04938473 |
| 18 | MP0006054_spinal_hemorrhage | 2.04377424 |
| 19 | MP0002163_abnormal_gland_morphology | 1.95826915 |
| 20 | MP0000604_amyloidosis | 1.90985091 |
| 21 | MP0003183_abnormal_peptide_metabolism | 1.86339156 |
| 22 | MP0004019_abnormal_vitamin_homeostasis | 1.80711148 |
| 23 | MP0000609_abnormal_liver_physiology | 1.77390102 |
| 24 | MP0002118_abnormal_lipid_homeostasis | 1.73409605 |
| 25 | MP0003705_abnormal_hypodermis_morpholog | 1.72047746 |
| 26 | MP0003868_abnormal_feces_composition | 1.67685984 |
| 27 | MP0008438_abnormal_cutaneous_collagen | 1.64577195 |
| 28 | MP0005319_abnormal_enzyme/_coenzyme | 1.60590189 |
| 29 | MP0009764_decreased_sensitivity_to | 1.57642343 |
| 30 | MP0002148_abnormal_hypersensitivity_rea | 1.55896433 |
| 31 | MP0010678_abnormal_skin_adnexa | 1.53234842 |
| 32 | MP0003950_abnormal_plasma_membrane | 1.49568649 |
| 33 | MP0002909_abnormal_adrenal_gland | 1.44669002 |
| 34 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.37256926 |
| 35 | MP0005058_abnormal_lysosome_morphology | 1.35114398 |
| 36 | MP0009697_abnormal_copulation | 1.33256966 |
| 37 | MP0002693_abnormal_pancreas_physiology | 1.29180694 |
| 38 | MP0004043_abnormal_pH_regulation | 1.28694337 |
| 39 | MP0002876_abnormal_thyroid_physiology | 1.27976275 |
| 40 | MP0002254_reproductive_system_inflammat | 1.25205896 |
| 41 | MP0001944_abnormal_pancreas_morphology | 1.18697421 |
| 42 | MP0009643_abnormal_urine_homeostasis | 1.18408742 |
| 43 | MP0003436_decreased_susceptibility_to | 1.18090078 |
| 44 | MP0004510_myositis | 1.13995185 |
| 45 | MP0003656_abnormal_erythrocyte_physiolo | 1.13897118 |
| 46 | MP0008469_abnormal_protein_level | 1.11130348 |
| 47 | MP0005167_abnormal_blood-brain_barrier | 1.10464941 |
| 48 | MP0003303_peritoneal_inflammation | 1.08345018 |
| 49 | MP0003690_abnormal_glial_cell | 1.08070549 |
| 50 | MP0006082_CNS_inflammation | 1.06961725 |
| 51 | MP0003329_amyloid_beta_deposits | 1.04312517 |
| 52 | MP0005646_abnormal_pituitary_gland | 1.00791945 |
| 53 | MP0009780_abnormal_chondrocyte_physiolo | 1.00469070 |
| 54 | MP0003724_increased_susceptibility_to | 0.99621763 |
| 55 | MP0005166_decreased_susceptibility_to | 0.99594117 |
| 56 | MP0005310_abnormal_salivary_gland | 0.97199432 |
| 57 | MP0010386_abnormal_urinary_bladder | 0.95804507 |
| 58 | MP0005647_abnormal_sex_gland | 0.95754160 |
| 59 | MP0001764_abnormal_homeostasis | 0.94052367 |
| 60 | MP0000569_abnormal_digit_pigmentation | 0.93795634 |
| 61 | MP0009763_increased_sensitivity_to | 0.92214346 |
| 62 | MP0001756_abnormal_urination | 0.91367106 |
| 63 | MP0000343_altered_response_to | 0.91013971 |
| 64 | MP0009046_muscle_twitch | 0.90864541 |
| 65 | MP0010352_gastrointestinal_tract_polyps | 0.90783296 |
| 66 | MP0000538_abnormal_urinary_bladder | 0.90331582 |
| 67 | MP0001790_abnormal_immune_system | 0.89761765 |
| 68 | MP0005387_immune_system_phenotype | 0.89761765 |
| 69 | MP0005535_abnormal_body_temperature | 0.88899712 |
| 70 | MP0005636_abnormal_mineral_homeostasis | 0.88838511 |
| 71 | MP0003075_altered_response_to | 0.87603079 |
| 72 | MP0000598_abnormal_liver_morphology | 0.87001299 |
| 73 | MP0001533_abnormal_skeleton_physiology | 0.86951282 |
| 74 | MP0009384_cardiac_valve_regurgitation | 0.86728994 |
| 75 | MP0003879_abnormal_hair_cell | 0.86031847 |
| 76 | MP0003300_gastrointestinal_ulcer | 0.85256561 |
| 77 | MP0009642_abnormal_blood_homeostasis | 0.84835549 |
| 78 | MP0004858_abnormal_nervous_system | 0.84732280 |
| 79 | MP0005084_abnormal_gallbladder_morpholo | 0.84102522 |
| 80 | MP0005220_abnormal_exocrine_pancreas | 0.82273375 |
| 81 | MP0004130_abnormal_muscle_cell | 0.81600903 |
| 82 | MP0005164_abnormal_response_to | 0.81262337 |
| 83 | MP0005464_abnormal_platelet_physiology | 0.80841076 |
| 84 | MP0003172_abnormal_lysosome_physiology | 0.80257219 |
| 85 | MP0002332_abnormal_exercise_endurance | 0.80016106 |
| 86 | MP0002168_other_aberrant_phenotype | 0.78547600 |
| 87 | MP0002090_abnormal_vision | 0.78300989 |
| 88 | MP0002295_abnormal_pulmonary_circulatio | 0.78229606 |
| 89 | MP0002078_abnormal_glucose_homeostasis | 0.77335880 |
| 90 | MP0005257_abnormal_intraocular_pressure | 0.76990225 |
| 91 | MP0010368_abnormal_lymphatic_system | 0.74395362 |
| 92 | MP0002419_abnormal_innate_immunity | 0.73636364 |
| 93 | MP0000516_abnormal_urinary_system | 0.73323868 |
| 94 | MP0005367_renal/urinary_system_phenotyp | 0.73323868 |
| 95 | MP0009765_abnormal_xenobiotic_induced | 0.72800153 |
| 96 | MP0002136_abnormal_kidney_physiology | 0.72292754 |
| 97 | MP0005410_abnormal_fertilization | 0.70250276 |
| 98 | MP0001984_abnormal_olfaction | 0.70211865 |
| 99 | MP0002896_abnormal_bone_mineralization | 0.67777010 |
| 100 | MP0005334_abnormal_fat_pad | 0.65889202 |
| 101 | MP0005165_increased_susceptibility_to | 0.65805454 |
| 102 | MP0001501_abnormal_sleep_pattern | 0.65425056 |
| 103 | MP0005275_abnormal_skin_tensile | 0.65325351 |
| 104 | MP0003011_delayed_dark_adaptation | 0.64025584 |
| 105 | MP0002998_abnormal_bone_remodeling | 0.63876718 |
| 106 | MP0005551_abnormal_eye_electrophysiolog | 0.63632074 |
| 107 | MP0005448_abnormal_energy_balance | 0.62192600 |
| 108 | MP0003186_abnormal_redox_activity | 0.61710882 |
| 109 | MP0003953_abnormal_hormone_level | 0.60456702 |
| 110 | MP0008872_abnormal_physiological_respon | 0.60141108 |
| 111 | MP0005395_other_phenotype | 0.60111758 |
| 112 | MP0009785_altered_susceptibility_to | 0.59615337 |
| 113 | MP0002971_abnormal_brown_adipose | 0.58644655 |
| 114 | MP0002928_abnormal_bile_duct | 0.58518050 |
| 115 | MP0000427_abnormal_hair_cycle | 0.58461307 |
| 116 | MP0001845_abnormal_inflammatory_respons | 0.57987709 |
| 117 | MP0005376_homeostasis/metabolism_phenot | 0.57904837 |
| 118 | MP0005000_abnormal_immune_tolerance | 0.57880265 |
| 119 | MP0005503_abnormal_tendon_morphology | 0.57819398 |
| 120 | MP0008874_decreased_physiological_sensi | 0.57606270 |
| 121 | MP0000685_abnormal_immune_system | 0.56768211 |
| 122 | MP0009745_abnormal_behavioral_response | 0.56750820 |
| 123 | MP0001542_abnormal_bone_strength | 0.56641589 |
| 124 | MP0000230_abnormal_systemic_arterial | 0.55770185 |
| 125 | MP0001881_abnormal_mammary_gland | 0.54825102 |
| 126 | MP0001661_extended_life_span | 0.54346853 |
| 127 | MP0001765_abnormal_ion_homeostasis | 0.53258521 |
| 128 | MP0005408_hypopigmentation | 0.53183905 |
| 129 | MP0003633_abnormal_nervous_system | 0.53156438 |
| 130 | MP0010234_abnormal_vibrissa_follicle | 0.52446705 |
| 131 | MP0004947_skin_inflammation | 0.51909621 |
| 132 | MP0003091_abnormal_cell_migration | 0.51332910 |
| 133 | MP0001835_abnormal_antigen_presentation | 0.51104565 |
| 134 | MP0005197_abnormal_uvea_morphology | 0.50111887 |
| 135 | MP0004883_abnormal_blood_vessel | 0.49901056 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Complement deficiency (HP:0004431) | 6.08420453 |
| 2 | Deep venous thrombosis (HP:0002625) | 6.06088729 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 5.65568055 |
| 4 | Prolonged partial thromboplastin time (HP:0003645) | 5.28824006 |
| 5 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.15040713 |
| 6 | Xanthomatosis (HP:0000991) | 5.09772858 |
| 7 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.92495022 |
| 8 | Abnormality of glycolipid metabolism (HP:0010969) | 4.82561204 |
| 9 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.82561204 |
| 10 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.82561204 |
| 11 | Abnormality of complement system (HP:0005339) | 4.65220077 |
| 12 | Hypobetalipoproteinemia (HP:0003563) | 4.60648565 |
| 13 | Abnormality of the common coagulation pathway (HP:0010990) | 4.57066870 |
| 14 | Joint hemorrhage (HP:0005261) | 4.26853366 |
| 15 | Hyperlipoproteinemia (HP:0010980) | 4.10155486 |
| 16 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.06184221 |
| 17 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.01012229 |
| 18 | Epidermoid cyst (HP:0200040) | 3.88301895 |
| 19 | Systemic lupus erythematosus (HP:0002725) | 3.76279417 |
| 20 | Myocardial infarction (HP:0001658) | 3.71500644 |
| 21 | Spontaneous abortion (HP:0005268) | 3.68292029 |
| 22 | Hypolipoproteinemia (HP:0010981) | 3.63522374 |
| 23 | Conjugated hyperbilirubinemia (HP:0002908) | 3.59141209 |
| 24 | Fat malabsorption (HP:0002630) | 3.56674856 |
| 25 | Abnormality of the intrinsic pathway (HP:0010989) | 3.52300808 |
| 26 | Hypoalphalipoproteinemia (HP:0003233) | 3.32503320 |
| 27 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.32315883 |
| 28 | Generalized aminoaciduria (HP:0002909) | 3.27793019 |
| 29 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.22661971 |
| 30 | Glomerulonephritis (HP:0000099) | 3.20774888 |
| 31 | Hypothermia (HP:0002045) | 3.16397543 |
| 32 | Abnormality of vitamin metabolism (HP:0100508) | 3.11018567 |
| 33 | Hyperammonemia (HP:0001987) | 3.06662316 |
| 34 | Ketosis (HP:0001946) | 3.00516599 |
| 35 | Hematochezia (HP:0002573) | 3.00220157 |
| 36 | Abnormality of vitamin B metabolism (HP:0004340) | 2.94729814 |
| 37 | Hypercholesterolemia (HP:0003124) | 2.91089648 |
| 38 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.90730958 |
| 39 | Sensorimotor neuropathy (HP:0007141) | 2.88401668 |
| 40 | Skin nodule (HP:0200036) | 2.87839567 |
| 41 | Amyloidosis (HP:0011034) | 2.85777133 |
| 42 | Hyperglycinemia (HP:0002154) | 2.84629618 |
| 43 | Mitral stenosis (HP:0001718) | 2.77841653 |
| 44 | Mutism (HP:0002300) | 2.72174638 |
| 45 | Nuclear cataract (HP:0100018) | 2.71055380 |
| 46 | Disinhibition (HP:0000734) | 2.66887535 |
| 47 | Methylmalonic acidemia (HP:0002912) | 2.66169446 |
| 48 | Increased CSF protein (HP:0002922) | 2.65041470 |
| 49 | Glycosuria (HP:0003076) | 2.57846264 |
| 50 | Abnormality of urine glucose concentration (HP:0011016) | 2.57846264 |
| 51 | Abnormality of methionine metabolism (HP:0010901) | 2.57100717 |
| 52 | Gingival bleeding (HP:0000225) | 2.56331904 |
| 53 | Steatorrhea (HP:0002570) | 2.53380386 |
| 54 | Loss of speech (HP:0002371) | 2.49659788 |
| 55 | Nephritis (HP:0000123) | 2.49110598 |
| 56 | Hydroxyprolinuria (HP:0003080) | 2.45589480 |
| 57 | Abnormality of proline metabolism (HP:0010907) | 2.45589480 |
| 58 | Congenital sensorineural hearing impairment (HP:0008527) | 2.42682543 |
| 59 | Protuberant abdomen (HP:0001538) | 2.40560986 |
| 60 | Hepatocellular carcinoma (HP:0001402) | 2.38283593 |
| 61 | Azoospermia (HP:0000027) | 2.37215206 |
| 62 | Abnormality of glycine metabolism (HP:0010895) | 2.36954734 |
| 63 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.36954734 |
| 64 | Hyperglycinuria (HP:0003108) | 2.34151009 |
| 65 | Peritonitis (HP:0002586) | 2.31348006 |
| 66 | Methylmalonic aciduria (HP:0012120) | 2.30986842 |
| 67 | Ketoacidosis (HP:0001993) | 2.30203101 |
| 68 | Abnormality of purine metabolism (HP:0004352) | 2.30188436 |
| 69 | Thyroiditis (HP:0100646) | 2.29373332 |
| 70 | Abnormality of nucleobase metabolism (HP:0010932) | 2.29131740 |
| 71 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.27188979 |
| 72 | Mucopolysacchariduria (HP:0008155) | 2.27188979 |
| 73 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.27018349 |
| 74 | Proximal tubulopathy (HP:0000114) | 2.25410738 |
| 75 | Cholecystitis (HP:0001082) | 2.25001919 |
| 76 | Abnormal gallbladder physiology (HP:0012438) | 2.25001919 |
| 77 | Hypoglycemic coma (HP:0001325) | 2.23948150 |
| 78 | Conjunctival hamartoma (HP:0100780) | 2.23832478 |
| 79 | Vascular calcification (HP:0004934) | 2.23719280 |
| 80 | Hyperglycemia (HP:0003074) | 2.19997007 |
| 81 | Cardiovascular calcification (HP:0011915) | 2.19856706 |
| 82 | Exocrine pancreatic insufficiency (HP:0001738) | 2.16423045 |
| 83 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.16404284 |
| 84 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.16404284 |
| 85 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.16404284 |
| 86 | Renal cortical cysts (HP:0000803) | 2.16158698 |
| 87 | Hemiparesis (HP:0001269) | 2.16108832 |
| 88 | Late onset (HP:0003584) | 2.14423454 |
| 89 | Progressive macrocephaly (HP:0004481) | 2.14421627 |
| 90 | Menorrhagia (HP:0000132) | 2.12873916 |
| 91 | Malnutrition (HP:0004395) | 2.12809488 |
| 92 | Hyperbilirubinemia (HP:0002904) | 2.09023065 |
| 93 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.06544497 |
| 94 | Thrombophlebitis (HP:0004418) | 2.05661554 |
| 95 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.02386575 |
| 96 | Esophageal varix (HP:0002040) | 2.02378584 |
| 97 | Acanthocytosis (HP:0001927) | 2.01839539 |
| 98 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.00469961 |
| 99 | Hyperventilation (HP:0002883) | 1.98284032 |
| 100 | Vacuolated lymphocytes (HP:0001922) | 1.97620810 |
| 101 | Abnormal gallbladder morphology (HP:0012437) | 1.97482921 |
| 102 | Dysostosis multiplex (HP:0000943) | 1.96626596 |
| 103 | Stomatitis (HP:0010280) | 1.96502666 |
| 104 | Symptomatic seizures (HP:0011145) | 1.95180155 |
| 105 | Progressive neurologic deterioration (HP:0002344) | 1.94727585 |
| 106 | Status epilepticus (HP:0002133) | 1.94103991 |
| 107 | Axonal loss (HP:0003447) | 1.91491018 |
| 108 | Cholelithiasis (HP:0001081) | 1.90633593 |
| 109 | Hamartoma of the eye (HP:0010568) | 1.89871886 |
| 110 | Prolonged neonatal jaundice (HP:0006579) | 1.89188523 |
| 111 | Abnormality of the renal cortex (HP:0011035) | 1.87862977 |
| 112 | Albinism (HP:0001022) | 1.87857564 |
| 113 | Agitation (HP:0000713) | 1.87601872 |
| 114 | Hypophosphatemic rickets (HP:0004912) | 1.86900006 |
| 115 | Zonular cataract (HP:0010920) | 1.86517035 |
| 116 | Hypoglycemic seizures (HP:0002173) | 1.86242918 |
| 117 | Postural tremor (HP:0002174) | 1.86229071 |
| 118 | Irritability (HP:0000737) | 1.85599463 |
| 119 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.85531787 |
| 120 | Tongue fasciculations (HP:0001308) | 1.84315766 |
| 121 | Neonatal onset (HP:0003623) | 1.83885529 |
| 122 | Muscular hypotonia of the trunk (HP:0008936) | 1.82946120 |
| 123 | Lethargy (HP:0001254) | 1.82186783 |
| 124 | Abnormality of the lumbar spine (HP:0100712) | 1.81824540 |
| 125 | Stroke (HP:0001297) | 1.81373374 |
| 126 | Bone cyst (HP:0012062) | 1.79935328 |
| 127 | Pancreatitis (HP:0001733) | 1.79664023 |
| 128 | Pigmentary retinal degeneration (HP:0001146) | 1.78943934 |
| 129 | Hemorrhage of the eye (HP:0011885) | 1.77481989 |
| 130 | Metaphyseal irregularity (HP:0003025) | 1.77352843 |
| 131 | 3-Methylglutaconic aciduria (HP:0003535) | 1.76511696 |
| 132 | Hypokinesia (HP:0002375) | 1.76031239 |
| 133 | Abnormality of serum amino acid levels (HP:0003112) | 1.73470322 |
| 134 | Gout (HP:0001997) | 1.72641484 |
| 135 | Medial flaring of the eyebrow (HP:0010747) | 1.71811308 |
| 136 | Large for gestational age (HP:0001520) | 1.71377250 |
| 137 | Metabolic acidosis (HP:0001942) | 1.70735783 |
| 138 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.70603468 |
| 139 | Acute necrotizing encephalopathy (HP:0006965) | 1.70531156 |
| 140 | Joint swelling (HP:0001386) | 1.70250630 |
| 141 | Intention tremor (HP:0002080) | 1.70078451 |
| 142 | Inappropriate behavior (HP:0000719) | 1.69905247 |
| 143 | Metaphyseal dysplasia (HP:0100255) | 1.69882019 |
| 144 | Nausea (HP:0002018) | 1.69226329 |
| 145 | Abnormal tarsal ossification (HP:0008369) | 1.68772121 |
| 146 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.68558243 |
| 147 | Cardiomegaly (HP:0001640) | 1.68035423 |
| 148 | Arthropathy (HP:0003040) | 1.67257712 |
| 149 | Upper motor neuron abnormality (HP:0002127) | 1.67150364 |
| 150 | Abnormality of the gallbladder (HP:0005264) | 1.65786892 |
| 151 | Ectopia lentis (HP:0001083) | 1.64690147 |
| 152 | Elevated alkaline phosphatase (HP:0003155) | 1.64208915 |
| 153 | Lower limb hyperreflexia (HP:0002395) | 1.63403710 |
| 154 | Rickets (HP:0002748) | 1.61907434 |
| 155 | Abnormal delivery (HP:0001787) | 1.61579685 |
| 156 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.60398948 |
| 157 | Tetraparesis (HP:0002273) | 1.59774778 |
| 158 | Spastic diplegia (HP:0001264) | 1.59419555 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 3.97401305 |
| 2 | TAOK3 | 3.40748648 |
| 3 | FRK | 3.33362575 |
| 4 | MST4 | 2.97739850 |
| 5 | TRIM28 | 2.69294378 |
| 6 | MAP4K2 | 2.62649620 |
| 7 | ACVR1B | 2.61599430 |
| 8 | MAP3K12 | 2.60855006 |
| 9 | ERBB4 | 2.58467314 |
| 10 | ADRBK2 | 2.48444209 |
| 11 | FGFR4 | 2.37700165 |
| 12 | BCKDK | 2.25814059 |
| 13 | INSRR | 2.21778138 |
| 14 | BCR | 2.11465487 |
| 15 | SIK1 | 2.10505661 |
| 16 | AKT3 | 2.10044836 |
| 17 | ERBB3 | 1.98441336 |
| 18 | GRK1 | 1.92546238 |
| 19 | LATS1 | 1.89152322 |
| 20 | MAP3K14 | 1.85929002 |
| 21 | MAP2K4 | 1.84161542 |
| 22 | DAPK2 | 1.75419786 |
| 23 | GRK7 | 1.74846924 |
| 24 | NEK9 | 1.73909459 |
| 25 | MST1R | 1.72361327 |
| 26 | JAK1 | 1.71815656 |
| 27 | STK24 | 1.71356647 |
| 28 | TYK2 | 1.70406681 |
| 29 | EPHA3 | 1.66408632 |
| 30 | BMPR1B | 1.60138779 |
| 31 | OXSR1 | 1.59451009 |
| 32 | PIK3CG | 1.57579813 |
| 33 | STK39 | 1.56317586 |
| 34 | MAP3K2 | 1.49114739 |
| 35 | TBK1 | 1.46093784 |
| 36 | NTRK1 | 1.46023370 |
| 37 | CSNK1G1 | 1.43520158 |
| 38 | MAP3K13 | 1.42371899 |
| 39 | CASK | 1.37126257 |
| 40 | RIPK4 | 1.33972774 |
| 41 | EIF2AK3 | 1.29137707 |
| 42 | MAP3K3 | 1.26193540 |
| 43 | CSNK1G2 | 1.24728414 |
| 44 | LMTK2 | 1.21405348 |
| 45 | TGFBR2 | 1.20051455 |
| 46 | CSNK1G3 | 1.19733123 |
| 47 | DDR2 | 1.18966800 |
| 48 | MAP3K9 | 1.17742009 |
| 49 | LATS2 | 1.17332242 |
| 50 | RIPK1 | 1.15562108 |
| 51 | TRPM7 | 1.13939987 |
| 52 | PTK6 | 1.10187362 |
| 53 | IRAK3 | 1.07166285 |
| 54 | PHKG1 | 1.04825555 |
| 55 | PHKG2 | 1.04825555 |
| 56 | SIK3 | 1.04446830 |
| 57 | SGK3 | 0.98451069 |
| 58 | PINK1 | 0.98343529 |
| 59 | CSNK1A1L | 0.97434698 |
| 60 | JAK2 | 0.96772907 |
| 61 | RET | 0.96488258 |
| 62 | MAP3K4 | 0.96004325 |
| 63 | MAP2K7 | 0.95142287 |
| 64 | ABL2 | 0.94969862 |
| 65 | TNIK | 0.93922131 |
| 66 | WNK3 | 0.91952174 |
| 67 | SGK2 | 0.91605921 |
| 68 | MAP2K6 | 0.91563439 |
| 69 | NTRK3 | 0.91382379 |
| 70 | STK38L | 0.91147042 |
| 71 | FER | 0.90327434 |
| 72 | NLK | 0.88375021 |
| 73 | CAMK1D | 0.88064810 |
| 74 | PRKCZ | 0.87972790 |
| 75 | TRIB3 | 0.85831601 |
| 76 | TAOK1 | 0.85504739 |
| 77 | FGFR3 | 0.85256594 |
| 78 | MAPK11 | 0.84025742 |
| 79 | LIMK1 | 0.82566777 |
| 80 | PRKCH | 0.82137913 |
| 81 | CAMKK1 | 0.81677306 |
| 82 | BMPR2 | 0.80030569 |
| 83 | TXK | 0.77983381 |
| 84 | MAP2K1 | 0.77838892 |
| 85 | PLK2 | 0.77027374 |
| 86 | MARK1 | 0.76170942 |
| 87 | EPHB1 | 0.75645006 |
| 88 | PDK2 | 0.72090410 |
| 89 | STK3 | 0.71458964 |
| 90 | BMX | 0.71091783 |
| 91 | PAK3 | 0.68265702 |
| 92 | PTK2 | 0.67328637 |
| 93 | KSR2 | 0.65586062 |
| 94 | MATK | 0.64726519 |
| 95 | SGK494 | 0.64635961 |
| 96 | SGK223 | 0.64635961 |
| 97 | PRKCG | 0.64613465 |
| 98 | PRKAA2 | 0.63221102 |
| 99 | PTK2B | 0.62771977 |
| 100 | PIM2 | 0.62228712 |
| 101 | PRKCE | 0.61053590 |
| 102 | CAMK1G | 0.60941873 |
| 103 | PDPK1 | 0.59201581 |
| 104 | ERBB2 | 0.59026214 |
| 105 | CHUK | 0.58684527 |
| 106 | MINK1 | 0.58612192 |
| 107 | MAP3K1 | 0.56739355 |
| 108 | GSK3A | 0.56301376 |
| 109 | CAMKK2 | 0.54878167 |
| 110 | JAK3 | 0.54498375 |
| 111 | CSF1R | 0.54282202 |
| 112 | EGFR | 0.53690711 |
| 113 | CSK | 0.52458896 |
| 114 | KIT | 0.51275974 |
| 115 | MAPK12 | 0.51257205 |
| 116 | PDGFRA | 0.51027840 |
| 117 | PRKACG | 0.50954058 |
| 118 | PAK6 | 0.50917538 |
| 119 | STK38 | 0.50897084 |
| 120 | PRKAA1 | 0.50430820 |
| 121 | IKBKB | 0.49613576 |
| 122 | MAP3K7 | 0.48968722 |
| 123 | GRK6 | 0.48282699 |
| 124 | IGF1R | 0.47235021 |
| 125 | PRKG2 | 0.46439189 |
| 126 | CAMK2G | 0.45867755 |
| 127 | ROCK1 | 0.45700660 |
| 128 | WNK4 | 0.44913179 |
| 129 | IKBKE | 0.44870561 |
| 130 | CAMK2D | 0.44686303 |
| 131 | PIK3CA | 0.43497181 |
| 132 | PRKCI | 0.42955043 |
| 133 | PKN1 | 0.41943715 |
| 134 | PRKCQ | 0.41376222 |
| 135 | CSNK1A1 | 0.41192188 |
| 136 | MAP3K5 | 0.40557279 |
| 137 | FGR | 0.40012118 |
| 138 | IRAK1 | 0.39992527 |
| 139 | CAMK2A | 0.39931971 |
| 140 | FGFR2 | 0.39739473 |
| 141 | FLT3 | 0.39616448 |
| 142 | EPHA4 | 0.39317864 |
| 143 | MYLK | 0.38977046 |
| 144 | MAPK13 | 0.38648384 |
| 145 | ABL1 | 0.37268242 |
| 146 | TESK1 | 0.37264672 |
| 147 | EIF2AK1 | 0.37159711 |
| 148 | ADRBK1 | 0.37071299 |
| 149 | DAPK1 | 0.33479912 |
| 150 | PRKG1 | 0.32720575 |
| 151 | PRKCA | 0.28715953 |
| 152 | MET | 0.27162740 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.29601491 |
| 2 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 3.30492321 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.16939158 |
| 4 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.09875531 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.01550694 |
| 6 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.88633046 |
| 7 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.43794476 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.37721388 |
| 9 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.15002535 |
| 10 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.95683309 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.95316035 |
| 12 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.89203691 |
| 13 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.84289846 |
| 14 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.77534954 |
| 15 | Peroxisome_Homo sapiens_hsa04146 | 1.75714705 |
| 16 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.75406209 |
| 17 | Protein export_Homo sapiens_hsa03060 | 1.71109606 |
| 18 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.69880968 |
| 19 | Bile secretion_Homo sapiens_hsa04976 | 1.69561722 |
| 20 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.67689912 |
| 21 | Histidine metabolism_Homo sapiens_hsa00340 | 1.58589748 |
| 22 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.54094405 |
| 23 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.53155842 |
| 24 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.51689392 |
| 25 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.46785133 |
| 26 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.44597218 |
| 27 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.43933605 |
| 28 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.43752179 |
| 29 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.37222185 |
| 30 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.32271084 |
| 31 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.30464014 |
| 32 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.29776816 |
| 33 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.28102074 |
| 34 | Retinol metabolism_Homo sapiens_hsa00830 | 1.26981047 |
| 35 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.26875608 |
| 36 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.26760379 |
| 37 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.24139747 |
| 38 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.23313332 |
| 39 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.22495079 |
| 40 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.22488014 |
| 41 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.20168902 |
| 42 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.18226256 |
| 43 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.16106528 |
| 44 | Asthma_Homo sapiens_hsa05310 | 1.15565700 |
| 45 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.13132183 |
| 46 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.08276231 |
| 47 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.07629417 |
| 48 | ABC transporters_Homo sapiens_hsa02010 | 1.05790533 |
| 49 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.05171896 |
| 50 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.00896506 |
| 51 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.00192913 |
| 52 | Prion diseases_Homo sapiens_hsa05020 | 0.97039417 |
| 53 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.91279629 |
| 54 | Legionellosis_Homo sapiens_hsa05134 | 0.90443623 |
| 55 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.89133087 |
| 56 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.88498647 |
| 57 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.87170700 |
| 58 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.85062612 |
| 59 | Allograft rejection_Homo sapiens_hsa05330 | 0.84336667 |
| 60 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.83484506 |
| 61 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.80063294 |
| 62 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.78892876 |
| 63 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.78835275 |
| 64 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.78202487 |
| 65 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.77526760 |
| 66 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.73549792 |
| 67 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.72104341 |
| 68 | Circadian rhythm_Homo sapiens_hsa04710 | 0.70971808 |
| 69 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.69937813 |
| 70 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.69275019 |
| 71 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.68158466 |
| 72 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.67880912 |
| 73 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.66561472 |
| 74 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.66127929 |
| 75 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.65979431 |
| 76 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.65377117 |
| 77 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.63124610 |
| 78 | Lysosome_Homo sapiens_hsa04142 | 0.61236600 |
| 79 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.59937354 |
| 80 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.59519441 |
| 81 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.58449849 |
| 82 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.55814959 |
| 83 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.54690211 |
| 84 | Lysine degradation_Homo sapiens_hsa00310 | 0.54496125 |
| 85 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.53885166 |
| 86 | Carbon metabolism_Homo sapiens_hsa01200 | 0.50993759 |
| 87 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.50784736 |
| 88 | Insulin secretion_Homo sapiens_hsa04911 | 0.50677212 |
| 89 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.49460612 |
| 90 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.49444131 |
| 91 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.45160131 |
| 92 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.44604073 |
| 93 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.44482040 |
| 94 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.44297531 |
| 95 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.43452671 |
| 96 | Phototransduction_Homo sapiens_hsa04744 | 0.42575075 |
| 97 | Salmonella infection_Homo sapiens_hsa05132 | 0.42172328 |
| 98 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.41806655 |
| 99 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.41628487 |
| 100 | Phagosome_Homo sapiens_hsa04145 | 0.41066916 |
| 101 | Amoebiasis_Homo sapiens_hsa05146 | 0.39701464 |
| 102 | Insulin resistance_Homo sapiens_hsa04931 | 0.39195625 |
| 103 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.38021146 |
| 104 | Pertussis_Homo sapiens_hsa05133 | 0.34568691 |
| 105 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.34499244 |
| 106 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.33945671 |
| 107 | Mineral absorption_Homo sapiens_hsa04978 | 0.30391594 |
| 108 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.30058508 |
| 109 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.27681470 |
| 110 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.26710040 |
| 111 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.26361181 |
| 112 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.25979106 |
| 113 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.25681485 |
| 114 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.25597664 |
| 115 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.25461527 |
| 116 | Malaria_Homo sapiens_hsa05144 | 0.25163462 |
| 117 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.22016660 |
| 118 | Tuberculosis_Homo sapiens_hsa05152 | 0.21566688 |
| 119 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.20818013 |
| 120 | Sulfur relay system_Homo sapiens_hsa04122 | 0.20361616 |
| 121 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.19459046 |
| 122 | Galactose metabolism_Homo sapiens_hsa00052 | 0.19442912 |
| 123 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.19367191 |
| 124 | Hepatitis C_Homo sapiens_hsa05160 | 0.16804932 |
| 125 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.16128925 |
| 126 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.15195456 |
| 127 | Metabolic pathways_Homo sapiens_hsa01100 | 0.15184137 |
| 128 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.14565555 |
| 129 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.14565150 |
| 130 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.14553299 |
| 131 | Leishmaniasis_Homo sapiens_hsa05140 | 0.13633601 |
| 132 | Other glycan degradation_Homo sapiens_hsa00511 | 0.10880750 |
| 133 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.10584098 |

